Flomoxef sodium

This classification denotes a cephalosporin antibiotic with the molecular structure C15H17F2N6O7S2.NA, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 445HIB8XNF chemically known as 5-oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((((difluoromethyl)thio)acetyl)amino)-3-(((1-(2-hydroxyethyl)-1h-tetrazol-5-yl)thio)methyl)-7-methoxy-8-oxo-, sodium salt (1:1), (6r,7r)-, but more commonly known as flomoxef sodium, which bears US NIH Compound Identifier 443982. European Medicines Agency schedules Flomoxef sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02203MIG. Most nations, for tariff and trade purposes, schedule flomoxef sodium under HS 29419000 and SITC 54139. As of Q4 2014, FLOMOXEF SODIUM remains US FDA's Preferred Term for this commodity. SMILES: CO[C@@]1([C@@H]2N(C1=O)C(=C(CO2)CSC3NNNN3CCO)C(=O)[O-])NC(=O)CSC(F)F.[NA+].